IN THE NEWS

M&A Deal Fatigue

Published October 10th 2023

olume 10, Issue 21, October 10, 2023

Mergers and acquisitions (M+A) are complex transactions that involve multiple parties, intricate negotiations, and significant financial investments. While the excitement surrounding potential synergies and growth/exit opportunities often takes center stage, there is a lesser-known, yet equally important factor that can significantly impact the success of an M&A deal: deal fatigue.

Deal fatigue refers to the exhaustion, frustration, and reduced enthusiasm that can set in over time among key stakeholders involved in an M+A transaction, both from the seller’s side and the buyers’ side. It is a phenomenon that can gradually erode the effectiveness of the deal-making process. If not managed properly, deal fatigue can ultimately jeopardize the entire transaction, which we at VERTESS have witnessed firsthand.

In this column, I will explore how deal fatigue can impact an M+A transaction and share some strategies to mitigate its effects.

The Phases of an M+A Transaction

To understand the impact of deal fatigue, it's important to first understand the different phases of an M+A transaction.

Pre-transaction This phase involves identifying potential acquisition targets or buyers, conducting financial and operational due diligence, and structuring the deal.

Negotiation During this phase, both parties engage in negotiations to agree on the terms and conditions of the transaction, including the purchase price, asset allocation, and any contingencies. It’s important to understand that negotiating the limited terms in a letter of intent (LOI) is only the beginning of negotiations. You or your advisor will likely be negotiating on behalf of your company throughout the entire process.

Due diligence Once the deal terms are agreed upon and an executed LOI is in place, an in-depth due diligence process is initiated. The due diligence process involves reviewing financial, legal, operational, and cultural aspects of the target company. Due diligence varies from buyer to buyer and transaction to transaction, with the average time commitment around 90 days. On the shorter side, it can run 60 days. On the longer side, it can reach or even exceed 120 days.

Integration Post-closing, the integration phase begins. This is where the two organizations involved in the transaction merge their operations, cultures, and systems to realize the anticipated synergies and benefits of the transaction. This can easily be a 6-12 month process and involves numerous departments working together to make it as seamless as possible for staff.

A woman battles depression and stress in her workplace, highlighting the challenges faced by professionals. This image captures the impact of mental health on employees in a corporate environment.

How Deal Fatigue Can Impact M+A Transactions

Now let's look at some of the more common hurdles brought on by deal fatigue.

Reduced focus and diligence As an M+A transaction progresses, stakeholders may start to feel overwhelmed by the sheer volume of work and complexity involved. This is typically because sellers often haven’t been through the transaction process before and may not have a clear understanding of the work required. This can lead to a decrease in seller motivation and engagement, which can result in missed critical issues during due diligence or negotiation.

Extended timeline Deal fatigue can lead to delays as exhausted parties may request more time to review documents, make decisions, or simply take a break. These delays can increase costs and disrupt the transaction's momentum. No two buyers are the same, and their processes for due diligence won’t be either. I would say 8 out of 10 M+A deals I have worked on at VERTESS require an LOI extension to extend the due diligence period. This can take a mental hit on the parties involved as well.

Erosion of trust As fatigue sets in, trust between the parties can erode. This can manifest as increased skepticism or suspicion, making it harder to come to mutually beneficial agreements. This can also lead to what we call in the industry “re-trading,” where a buyer or seller changes terms or purchase price strategy or both shortly before closing. Re-trading is, at best, a difficult situation to weather and, at worst, a deal killer.

Deal breakdown In extreme cases, deal fatigue can become so pronounced that one or both parties decide to walk away from the transaction entirely, leading to wasted time, resources, and opportunities — not to mention the costs associated with a transaction for both buyer and seller (e.g., attorney's fees, quality of earnings (QofE) accounting firms, third-party diligence vendors).

Millennial black businesswoman addressing colleagues at a corporate business meeting, close up

Mitigating Deal Fatigue

The right plan can overcome the toughest challenges in a transaction, even daunting deal fatigue. Here are some of the key elements of such a plan.

Effective project management Implementing strong project management practices can help keep a deal on track and ensure that deadlines are met. Clear timelines, milestones, and responsibilities should be established and monitored. A strong advisor and M+A firm will vastly increase the effectiveness and accountability for both sides during a transaction.

Open and transparent communication Maintain open and honest communication channels between all stakeholders. Address concerns and issues promptly to prevent them from escalating into deal-breaking problems, especially any legal woes the selling company has been party to.

Managing workload Ensure key team members are not overburdened with excessive work. Consider bringing in additional resources or expertise when needed to alleviate pressure. When we run a transaction process at VERTESS, we recommend our clients bring in 1-2 additional staff that can help pull diligence materials.

Setting realistic expectations Be realistic about the time and effort required for an M+A transaction. Overly aggressive timelines can contribute to deal fatigue. Setting appropriate expectations is another facet of a transaction a professional M+A team can walk through with you.

Flexibility Be willing to adapt and make reasonable concessions when necessary to keep the deal moving forward. Rigidity can exacerbate fatigue.

Red paper plane breaking through obstacle on blue background, Concept of overcoming barriers, goal, target

Don't Sleep on Deal Fatigue

Deal fatigue is a formidable but often underestimated challenge in the world of M+A transactions. Its impact can be subtle, gradually eroding the efficiency and effectiveness of the deal-making process.

By recognizing the signs of deal fatigue and implementing proactive measures to mitigate its effects, companies can increase their chances of successfully navigating the complex terrain of M+A transactions and achieving their strategic objectives. Effective deal management, open communication, and a focus on the well-being of all stakeholders are keys to mitigating the negative impact of deal fatigue and ensuring the long-term success of M+A deals.

Continue Reading

MORE NEWS

Healthcare Private Equity Update Through First Half of 2024

Private equity often carries a negative connotation in the healthcare industry. However, if you are considering selling ...
Read More

Importance of Sellers Helping Buyers Reduce Healthcare Acquisition Integration Costs

Why should a buyer's costs of integrating an acquired company be of interest to the seller? The most important reason is...
Read More

10 Reasons Why Healthcare Mergers Fail (and How to Avoid Them)

At least seven out of 10. That's at the low end of how many mergers and acquisitions (M+As) are likely to fail. The high...
Read More

5 Ways To Increase the Financial Value of a Healthcare Company

Owners of healthcare companies are accustomed to creating financial value for their businesses by focusing on the tradit...
Read More

Moving Your Healthcare Company up the Growth Ladder

Most successful companies reach points in their history where big decisions must be made that will determine whether the...
Read More

Quality of Earnings: The Big Obstacle to Healthcare Deal Success

A lot of merger and acquisition (M+A) deals fail. That's been the case for a long time. The M+A failure rate that's freq...
Read More

VERTESS Answers: Why Do I Need to Market My Company to Buyers?

If you own a healthcare company, you are probably receiving inquiries from interested buyers. We view this as buyers mar...
Read More

6 Recommendations To Run a Better ASC and Achieve a Successful Sale

Preparing an ambulatory surgery center (ASC) for a sale is a worthwhile process for center owners regardless of whether ...
Read More

Hospital at Home: A Shift in the Healthcare System

We're seeing a notable shift occurring in healthcare. While we have largely focused on how to enhance care delivery with...
Read More

VERTESS Answers: Should I Work With a Healthcare Advisor or Broker?

We will occasionally hear from the owner of a healthcare company something along the lines of the following: "I know som...
Read More

Parallels Between Early Clinical and Early Transaction Intervention

My educational and professional experiences have demonstrated to me the importance and value of early intervention, both...
Read More

Corporate Transparency Act: What It Is and What You Need To Do

The Corporate Transparency Act (CTA) went into effect on Jan. 1, 2024. This federal reporting requirement affects millio...
Read More

Are You Ready to Sell Your Healthcare Company?

After spending many years building your healthcare company, it's increasingly likely that you will find yourself thinkin...
Read More

DME Industry & 8 Strategies for Growth

By Bradley Smith, ATP, CM&AA Volume 3 Issue 22, October 25, 2016 Several years ago, DME competitive bidding was inst...
Read More

VirtuOx Makes Strategic Acquisition: Healthcare M&A

VirtuOx, a healthcare IT company providing diagnostic tools and services focused on sleep and respiratory disease states...
Read More

M&A: Home Medical Equipment

After a slow first quarter, buyer appetites for HME businesses are picking up, say M&A analysts.
Read More
1 2 3 41

COMMITTED TO CONSTANT IMPROVEMENT?

Want to stay current with trends in the medical/healthcare space as well as receive expert advice of veteran medical entrepreneurs?
SUBSCRIBE TO OUR BI-WEEKLY NEWSLETTER VERTESSPRESS
For over 10 years, we've been teaching ways you can improve the value of your healthcare company, focusing on informing you about mergers + acquisitions, including M+A trends in the healthcare market.
CHECK OUT VERTESSPRESS THE BLOG
No Spam Ever. We Promise
©2025 VERTESS. All Rights Reserved.